| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 6235144 | Journal of Affective Disorders | 2011 | 9 Pages |
Abstract
MIF is a promising new candidate in the neuro-immune interplay that may link depressive symptoms, altered immune state and HPA-axis dysregulation. Reduced levels of TGF-β replicate previous findings and support the importance of this regulatory cytokine in major depressive disorder.
Related Topics
Health Sciences
Medicine and Dentistry
Psychiatry and Mental Health
Authors
R. Musil, M.J. Schwarz, M. Riedel, S. Dehning, A. Cerovecki, I. Spellmann, V. Arolt, N. Müller,